It also helps reduce appetite by interacting with certain parts of the brain that process hunger and satiety
Specifically, the FDAs review of large trials and health records did not show an imbalance in suicide-related events between those on GLP-1 drugs and those on placebo (FDA update)
Wegovy (semaglutide) is primarily used for chronic weight management in adults and adolescents with obesity or those who are overweight with at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol
GHK-Cu published research history: - First isolated and characterized: 1973 - Continuous peer-reviewed publication: 50+ years - Published research covering: wound healing, skin biology, COPD, oxidative stress, bone, skeletal muscle, gastrointestinal, neurological, gene expression, aging - Mechanistic characterization: Multiple pathways identified, SIRT1 direct binding confirmed in 2025 - Cell and animal model validation: Extensive across multiple tissue types and species Matrixyl 3000 (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) research: - Commercial introduction: Early 2000s - Research base: Primarily cosmetic science and dermatology literature - Mechanistic characterization: Primarily focused on TGF-beta receptor and IL-6 pathways - Depth: Narrower tissue focus, smaller body of published mechanistic research For researchers who need a compound with extensive published mechanistic context, detailed gene expression data, or research across multiple tissue types, GHK-Cu's research depth is substantially greater
